About: AdAlta Limited, a clinical-stage biotechnology company, develops cellular immunotherapies for the treatment of solid cancers in Australia. The company also commercializes protein therapeutics. In addition, it engages in the development of AD-21, a protein therapeutic for fibrotic diseases, including lung fibrosis and kidney fibrosis in Phase 1 clinical studies; and WD-34, a discovery stage i-body for the treatment and prevention of malaria and related diseases. The company was incorporated in 2006 and is based in Hawthorn East, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.00 (-25.00%)
1AD ASX Adalta Ltd
Adalta Ltd share price
1AD price activity
Last Price
$0.000
Change (24hr)
-0.00 AUD (-25.00%)
Volume
505K
Volume (4w avg)
-
Open
$0.00
Day Range
$0.00 - $0.00
Previous Close
$0.00
Last Trade
05 Oct, 4:39 am GMT+0
Delayed
05 Oct, 4:39 am GMT+0
1AD price performance
Delayed
05 Oct, 4:39 am GMT+0
1AD Market Signals